MX9847A - Conjugados de inmunoglobulina y procedimiento para su preparacion. - Google Patents
Conjugados de inmunoglobulina y procedimiento para su preparacion.Info
- Publication number
- MX9847A MX9847A MX984787A MX984787A MX9847A MX 9847 A MX9847 A MX 9847A MX 984787 A MX984787 A MX 984787A MX 984787 A MX984787 A MX 984787A MX 9847 A MX9847 A MX 9847A
- Authority
- MX
- Mexico
- Prior art keywords
- preparation procedure
- immunoglobulin conjugates
- conjugates
- immunoglobulin
- procedure
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
- A61K47/6801—Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
- A61K47/6803—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
- A61K47/6807—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug or compound being a sugar, nucleoside, nucleotide, nucleic acid, e.g. RNA antisense
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Biochemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US94635186A | 1986-12-24 | 1986-12-24 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX9847A true MX9847A (es) | 1993-11-01 |
Family
ID=25484355
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX984787A MX9847A (es) | 1986-12-24 | 1987-12-18 | Conjugados de inmunoglobulina y procedimiento para su preparacion. |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP0272891A3 (es) |
| JP (1) | JPS63166897A (es) |
| KR (1) | KR880007531A (es) |
| CN (1) | CN1018649B (es) |
| AU (1) | AU590462B2 (es) |
| DK (1) | DK665187A (es) |
| HU (1) | HU205135B (es) |
| IE (1) | IE873450L (es) |
| IL (1) | IL84842A0 (es) |
| MX (1) | MX9847A (es) |
| NZ (1) | NZ222981A (es) |
| PT (1) | PT86377B (es) |
| RU (1) | RU1787160C (es) |
| ZA (1) | ZA879473B (es) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2075040T3 (es) * | 1988-02-16 | 1995-10-01 | Lilly Co Eli | 2',3'-dideoxi-2',2'-difluoronucleosidos. |
| MY104575A (en) * | 1989-12-22 | 1994-04-30 | The Wellcome Foundation Ltd | Therapeutic nucleosides. |
| IL97459A0 (en) * | 1990-03-09 | 1992-06-21 | Hybritech Inc | Trifunctional antibody-like compounds as a combined diagnostic and therapeutic agent |
| US5273743A (en) * | 1990-03-09 | 1993-12-28 | Hybritech Incorporated | Trifunctional antibody-like compounds as a combined diagnostic and therapeutic agent |
| WO1992014758A1 (en) * | 1991-02-13 | 1992-09-03 | The Austin Research Institute | Conjugate molecules |
| CN1076197C (zh) * | 1997-08-20 | 2001-12-19 | 许跃远 | 一种治疗乳腺疾病的药 |
| US6326507B1 (en) | 1998-06-19 | 2001-12-04 | Trustees Of Dartmouth College | Therapeutic compounds and methods of use |
| US7435755B2 (en) | 2000-11-28 | 2008-10-14 | The Trustees Of Dartmouth College | CDDO-compounds and combination therapies thereof |
| DK1465615T3 (da) | 2002-01-15 | 2012-11-12 | Dartmouth College | Tricykliske bisenonderivater og fremgangsmåder til anvendelse heraf |
| US7265096B2 (en) | 2002-11-04 | 2007-09-04 | Xenoport, Inc. | Gemcitabine prodrugs, pharmaceutical compositions and uses thereof |
| US8921340B2 (en) | 2006-11-17 | 2014-12-30 | Trustees Of Dartmouth College | Methods for using synthetic triterpenoids in the treatment of bone or cartilage diseases or conditions |
| WO2008064132A2 (en) | 2006-11-17 | 2008-05-29 | Trustees Of Dartmouth College | Synthetic triterpenoids and tricyclic-bis-enones for use in stimulating bone and cartilage growth |
| CA2670099A1 (en) | 2006-11-17 | 2008-05-29 | Trustees Of Dartmouth College | Synthesis and biological activities of new tricyclic-bis-enones (tbes) |
| CA2711834C (en) | 2008-01-11 | 2017-03-14 | Reata Pharmaceuticals, Inc. | Synthetic triterpenoids and methods of use in the treatment of disease |
| CN104250280A (zh) | 2008-04-18 | 2014-12-31 | 里亚塔医药公司 | 抗氧化剂炎症调节剂:c-17同系化齐墩果酸衍生物 |
| US7915402B2 (en) | 2008-04-18 | 2011-03-29 | Reata Pharmaceuticals, Inc. | Antioxidant inflammation modulators: oleanolic acid derivatives with saturation in the C-ring |
| MX339476B (es) | 2008-04-18 | 2016-05-27 | Reata Pharmaceuticals Inc | Compuestos que incluyen un nucleo farmaceutico antiinflamatorio y sus metodos de uso. |
| EA019263B1 (ru) | 2008-04-18 | 2014-02-28 | Ритэ Фамэсутикл, Инк. | Антиоксидативные модуляторы воспаления: производные олеанолевой кислоты с аминовыми и другими модификациями на с-17 |
| WO2009146216A2 (en) | 2008-04-18 | 2009-12-03 | Reata Pharmaceuticals. Inc. | Antioxidant inflammation modulators: novel derivatives of oleanolic acid |
| US8752322B2 (en) | 2012-01-13 | 2014-06-17 | Taurus International Manufacturing, Inc. | Body contoured handgun |
| EP2833905B1 (en) | 2012-04-04 | 2018-05-02 | Halozyme, Inc. | Combination therapy with hyaluronidase and a tumor-targeted taxane |
| US8921419B2 (en) | 2012-05-08 | 2014-12-30 | Trustees Of Dartmouth College | Triterpenoids and compositions containing the same |
| US20190351031A1 (en) | 2018-05-16 | 2019-11-21 | Halozyme, Inc. | Methods of selecting subjects for combination cancer therapy with a polymer-conjugated soluble ph20 |
| CN108610384B (zh) * | 2018-05-31 | 2022-02-22 | 沈阳药科大学 | 基于肠道mct1载体蛋白设计的前药及其制备方法 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4526988A (en) * | 1983-03-10 | 1985-07-02 | Eli Lilly And Company | Difluoro antivirals and intermediate therefor |
| GR79898B (es) * | 1983-03-30 | 1984-10-31 | Lilly Industries Ltd | |
| GR79899B (es) * | 1983-03-30 | 1984-10-31 | Lilly Industries Ltd | |
| US4650675A (en) * | 1983-08-18 | 1987-03-17 | The Children's Medical Center Corporation | Oligonucleotide conjugates |
| DE3587500T2 (de) * | 1984-12-04 | 1993-12-16 | Lilly Co Eli | Tumorbehandlung bei Säugetieren. |
| US4675400A (en) * | 1985-06-17 | 1987-06-23 | Eli Lilly And Company | Bifunctional derivatives of 4-desacetyl indole-dihydroindole alkaloids |
| CA1295998C (en) * | 1985-07-29 | 1992-02-18 | Sai P. Sunkara | Nucleosides and their use as antineoplastic agents |
| US4762823A (en) * | 1985-10-16 | 1988-08-09 | Sloan-Kettering Institute For Cancer Research | Nucleosides of 5-monofluoromethyluracil and 5-difluoromethyluracil |
| US4751221A (en) * | 1985-10-18 | 1988-06-14 | Sloan-Kettering Institute For Cancer Research | 2-fluoro-arabinofuranosyl purine nucleosides |
-
1987
- 1987-12-16 PT PT86377A patent/PT86377B/pt not_active IP Right Cessation
- 1987-12-16 IL IL84842A patent/IL84842A0/xx unknown
- 1987-12-16 RU SU874203967A patent/RU1787160C/ru active
- 1987-12-17 AU AU82659/87A patent/AU590462B2/en not_active Ceased
- 1987-12-17 DK DK665187A patent/DK665187A/da not_active Application Discontinuation
- 1987-12-17 ZA ZA879473A patent/ZA879473B/xx unknown
- 1987-12-17 KR KR870014370A patent/KR880007531A/ko not_active Application Discontinuation
- 1987-12-18 MX MX984787A patent/MX9847A/es unknown
- 1987-12-18 EP EP87311182A patent/EP0272891A3/en not_active Withdrawn
- 1987-12-18 JP JP62322619A patent/JPS63166897A/ja active Pending
- 1987-12-18 CN CN87108348A patent/CN1018649B/zh not_active Expired
- 1987-12-18 IE IE873450A patent/IE873450L/xx unknown
- 1987-12-18 NZ NZ222981A patent/NZ222981A/xx unknown
- 1987-12-18 HU HU875862A patent/HU205135B/hu not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| PT86377B (pt) | 1990-11-20 |
| PT86377A (en) | 1988-01-01 |
| ZA879473B (en) | 1989-08-30 |
| CN87108348A (zh) | 1988-07-13 |
| EP0272891A3 (en) | 1989-11-08 |
| CN1018649B (zh) | 1992-10-14 |
| KR880007531A (ko) | 1988-08-27 |
| EP0272891A2 (en) | 1988-06-29 |
| HUT45547A (en) | 1988-07-28 |
| RU1787160C (ru) | 1993-01-07 |
| HU205135B (en) | 1992-03-30 |
| AU8265987A (en) | 1988-06-30 |
| JPS63166897A (ja) | 1988-07-11 |
| DK665187D0 (da) | 1987-12-17 |
| NZ222981A (en) | 1989-08-29 |
| AU590462B2 (en) | 1989-11-02 |
| IE873450L (en) | 1988-06-24 |
| DK665187A (da) | 1988-06-25 |
| IL84842A0 (en) | 1988-06-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX9847A (es) | Conjugados de inmunoglobulina y procedimiento para su preparacion. | |
| MX7372A (es) | Drivados de tetrahidronaftalina e indano y procedimiento para su preparacion. | |
| MX9845A (es) | Propanaminas 3-ariloxi-3-substituidas y procedimiento para su preparacion. | |
| MX24568A (es) | 3-arilcarbonil-1h-indoles y procedimiento para su preparacion. | |
| IT8723244A0 (it) | Galattomannani modificati erelativo procedimento di preparazione. | |
| DE69014358D1 (de) | Kosmetisches Präparat. | |
| DK239687D0 (da) | Planteekstrakter | |
| MX14910A (es) | 2',3' -dideoxi-2',2'-difluoronucleosidos y procedimiento para su preparacion. | |
| MX16687A (es) | Compuestos de biarilo y procedimiento para su preparacion. | |
| MX26267A (es) | Aminobenzodiacepinas y procedimiento para su prepaacion. | |
| NO873080D0 (no) | Mikrobicid tilberedning. | |
| MX450A (es) | Composicion fijadora y procedimiento para su preparacion. | |
| MX9203090A (es) | Derivados de finilisopropilamina y su preparacion. | |
| DE68906762D1 (de) | Prostaglandin-polysaccharid-konjugat. | |
| DE3787051D1 (de) | Immunotestverfahren. | |
| MX22771A (es) | Alquil-polietoxietersulfatos y su procedimiento de obtencion. | |
| MX22255A (es) | Compuestos de piridinil-quinolona y procedimiento para su preparacion. | |
| MX21243A (es) | Indenoindoles y procedimiento para su preparacion. | |
| ES2022355B3 (es) | Polimeros de propileno y su preparacion. | |
| NO881105L (no) | Immunoglobulin-konjugater. | |
| IT8821300A0 (it) | Procedimento di preparazione di morniflumato e analoghi. | |
| NO873197D0 (no) | Bedoevelsespreparat og fremgangsmaate for anvendelse av dette. | |
| DK16489D0 (da) | Immunstimulerende praeparat. | |
| ES2014488B3 (es) | Procedimiento de preparacion de mercaptoalcoholes. | |
| AR240319A1 (es) | Procedimiento de preparacion de n-sulfamil-3-(2-guanidino-tiazol-4-il-metiltio)-propionamidina. |